CD47 and neoplasm: Indeed, CD47 blockade using monoclonal antibodies facilitates the clearance of PDAC cells via macrophage-dependent phagocytosis in in vitro engulfment assays, and decreases metastatic tumor burden and improves survival in mice [140].